- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HSP Market Currents
more »
-
May 14 Shares of Hospira (HSP -1.4%) dip after the company announced a voluntary recall over the weekend of one lot of its Hydromorphone Injection due to two reported complaints of a single Carpuject containing more than the 1 mL labeled fill volume. Pain medications such as Hydromorphone have life-threatening consequences if overdosed.
Comment![Healthcare]
HSP in Focus
more »
-
-
-
Wed, Oct 26, 2011 • 2 Comments
-
Tue, Oct 18, 2011 • Comment!
-
Wed, Jul 27, 2011 • Comment!
HSP Related Articles
more »
HSP News
more »
-
at MarketWatch.com (May 2, 2012)
-
at MarketWatch.com (May 1, 2012)
-
at MarketWatch.com (Apr 28, 2012)
-
at MarketWatch.com (Feb 17, 2012)
-
at MarketWatch.com (Feb 14, 2012)
HSP Press Releases and Filings
more »
-
PR Newswire (Thu, 2:12PM)
-
PR Newswire (May 9, 2012)
-
PR Newswire (May 8, 2012)
-
PR Newswire (May 1, 2012)
-
PR Newswire (Apr 26, 2012)
HSP Latest Transcript
more »
-
Tue, May 1
HSP Cramer
more »
-
Fri, Jul 11, 2008
HSP Instablog posts
more »
HSP vs. ETF Alternatives
Company Description
Hospira, Inc. ("Hospira") is a global specialty pharmaceutical and medication delivery company that develops, manufactures and markets products that help improve the safety, cost and productivity of patient care. Hospira's portfolio includes generic acute-care and oncology injectables, as well... More
